Demyashkin G.A.
Zaborskii I.N.
Research Clinical Center of JSC RZD, Department of Pathology with a Cytology Laboratory, Moscow, Russia.
I.M. Sechenov First Moscow State Medical University, A.I. Strukov Department of Pathology, Moscow, Russia.
A.F. Tsyb Medical Radiological Research Center - branch of the NMRRC, Obninsk, Russia, Obninsk, Russia.
New approach to diagnosis, immunophenotypic verification and prognostic prediction for renal angiomyolipoma
Текст визуальный электронный
Urologiia (Moscow, Russia : 1999)
№ 1 С. 35-41
2018
-SMA
HMB-45
Melan-A
diagnosis of renal angiomyolipoma
renal angiomyolipoma
Статья
Adult M01.060.116
Взрослые M01.060.116
Aged M01.060.116.100
Пожилые M01.060.116.100
Angiomyolipoma diagnostic imaging C04.557.450.550.125 C04.557.450.692.249
Angiomyolipoma pathology C04.557.450.550.125 C04.557.450.692.249
Angiomyolipoma surgery C04.557.450.550.125 C04.557.450.692.249
Ангиомиолипома диагностическое изображение C04.557.450.550.125 C04.557.450.692.249
Ангиомиолипома патология C04.557.450.550.125 C04.557.450.692.249
Ангиомиолипома хирургия C04.557.450.550.125 C04.557.450.692.249
Female
Женский
Humans B01.050.150.900.649.313.988.400.112.400.400
Человек B01.050.150.900.649.313.988.400.112.400.400
Immunohistochemistry E01.370.225.500.607.512 E01.370.225.750.551.512 E05.200.500.607.512 E05.200.750.551.512 E05.478.583 H01.158.100.656.234.512 H01.158.201.344.512 H01.158.201.486.512 H01.181.122.573.512 H01.181.122.605.512
Иммуногистохимия E01.370.225.500.607.512 E01.370.225.750.551.512 E05.200.500.607.512 E05.200.750.551.512 E05.478.583 H01.158.100.656.234.512 H01.158.201.344.512 H01.158.201.486.512 H01.181.122.573.512 H01.181.122.605.512
Kidney pathology A05.810.453
Kidney surgery A05.810.453
Почки патология A05.810.453
Почки хирургия A05.810.453
Kidney Neoplasms diagnostic imaging C04.588.945.947.535 C12.050.351.937.820.535 C12.050.351.968.419.473 C12.200.758.820.750 C12.200.777.419.473 C12.900.820.535 C12.950.419.473 C12.950.983.535
Kidney Neoplasms pathology C04.588.945.947.535 C12.050.351.937.820.535 C12.050.351.968.419.473 C12.200.758.820.750 C12.200.777.419.473 C12.900.820.535 C12.950.419.473 C12.950.983.535
Kidney Neoplasms surgery C04.588.945.947.535 C12.050.351.937.820.535 C12.050.351.968.419.473 C12.200.758.820.750 C12.200.777.419.473 C12.900.820.535 C12.950.419.473 C12.950.983.535
Почек новообразования диагностическое изображение C04.588.945.947.535 C12.050.351.937.820.535 C12.050.351.968.419.473 C12.200.758.820.750 C12.200.777.419.473 C12.900.820.535 C12.950.419.473 C12.950.983.535
Почек новообразования патология C04.588.945.947.535 C12.050.351.937.820.535 C12.050.351.968.419.473 C12.200.758.820.750 C12.200.777.419.473 C12.900.820.535 C12.950.419.473 C12.950.983.535
Почек новообразования хирургия C04.588.945.947.535 C12.050.351.937.820.535 C12.050.351.968.419.473 C12.200.758.820.750 C12.200.777.419.473 C12.900.820.535 C12.950.419.473 C12.950.983.535
Male
Мужской
Middle Aged M01.060.116.630
Средний возраст M01.060.116.630
Nephrectomy methods E04.950.774.435
Нефрэктомия методы E04.950.774.435
Predictive Value of Tests E05.318.370.800.650 N05.715.360.325.700.640 N06.850.520.445.800.650
Прогностическая ценность тестов E05.318.370.800.650 N05.715.360.325.700.640 N06.850.520.445.800.650
Prognosis E01.789
Прогноз E01.789
Retrospective Studies E05.318.372.500.500.500 E05.318.372.500.750.750 N05.715.360.330.500.500.500 N05.715.360.330.500.750.825 N06.850.520.450.500.500.500 N06.850.520.450.500.750.825
Ретроспективные исследования E05.318.372.500.500.500 E05.318.372.500.750.750 N05.715.360.330.500.500.500 N05.715.360.330.500.750.825 N06.850.520.450.500.500.500 N06.850.520.450.500.750.825
Tomography, X-Ray Computed E01.370.350.350.810 E01.370.350.600.350.700.810 E01.370.350.700.700.810 E01.370.350.700.810.810 E01.370.350.825.810.810
Томография рентгеновская компьютерная E01.370.350.350.810 E01.370.350.600.350.700.810 E01.370.350.700.700.810 E01.370.350.700.810.810 E01.370.350.825.810.810
Journal Article V02.600
Журнальная статья V02.600
Renal angiomyolipoma (AML) is a rare benign neoplasm of mesenchymal origin. AML incidence varies from 0.3 to 5[%], while women suffer four times more often than men. In most cases, renal AML measures less than 4 cm, is asymptomatic and detected accidentally with computed tomography or ultrasound. A histological variant of AML need to be verified to choose management strategy and reduce the risk of complications. Histological and immunohistochemical assessment of biopsy and surgical specimens has an essential diagnostic value in determining the type and subtypes of renal neoplasms and the risk of malignancy. The study aimed to investigate pathomorphological and prognostic features (immunohistochemical characteristics) of renal AML.